MedDeviceGuideMedDeviceGuide
Topic

Commercialization

203 articles

Regulatory

Pure Global AI: A Practical Workflow Guide for Medical Device Regulatory Teams

A vendor-neutral guide to Pure Global AI's regulatory databases, device and predicate agents, and evidence-first workpapers for risk, eSTAR, CAPA, QMSR, labeling, and post-market review.

›
Regulatory

NPWT Supplier Qualification: Pump–Dressing Compatibility, Alarms, QMS and Total Cost

A technical due-diligence guide for qualifying NPWT systems: pump-dressing compatibility, alarm performance, regulatory scope, and total cost of therapy.

›
Reimbursement & Market Access

Australia Prescribed List: Device Reimbursement Tiers, Fees and Benefit Reform

Complete guide to the Australia Prescribed List (formerly Prostheses List), covering application tiers, HPA pathways, 2026-27 cost recovery fees, benefit reductions, and post-listing review.

›
Reimbursement & Market Access

Medicare IPPS and MS-DRGs for Medical Devices: Inpatient Payment Guide

Guide to Medicare IPPS and MS-DRGs for medical devices, covering inpatient payment calculation, NTAP add-on payments, and the FY2027 Breakthrough overhaul.

›
Commercialization

China Volume-Based Procurement (VBP) for Medical Devices: Price Cuts & Strategy

Guide to China's NHSA volume-based procurement (VBP) for medical devices: round history, price cuts, provincial alliances, and multinational strategy.

›
Regulatory

FDA TAP Pilot Program Guide: Total Product Life Cycle Advisory Strategy

Guide to FDA CDRH Total Product Life Cycle Advisory (TAP) Pilot Program, Breakthrough Device eligibility, 14-day advisor meetings, and CMS payor alignment.

›
Reimbursement & Market Access

Commercial Insurance Coverage for Medical Devices: Payer Policy and Prior Auth

Guide to US commercial and private-payer coverage for medical devices — medical policy, prior authorization, ERISA self-funded plans, appeals, and the Medicare NCD/LCD benchmark.

›
Commercialization

Teleflex Global Regulatory Dossier: Arrow, UroLift, FDA Data & 2025 Sale

Data-driven regulatory dossier of Teleflex (NYSE: TFX): ~440 FDA 510(k)s, multi-country registration counts, Arrow Class I recalls, and the 2025 $2.03B divestiture.

›
Supply Chain

Defense Production Act & Buy American for Medical Devices (2026)

A decision guide for medical device makers on U.S. domestic incentives: DPA Title III grants, Buy American Act thresholds, TAA exemptions, and tax rules.

›
Clinical Evidence

How to Choose a Medical Device CRO: Selection & Due Diligence (2026)

Vendor-neutral guide to selecting a medical device CRO: ISO 14155:2026 and ICH E6(R3) compliance, RFP execution, FDA 483 due diligence, and cost models.

›
Regulatory

FCPA Compliance for Medical Device Manufacturers: 2025 Shifts and Case Record

A guide to US FCPA compliance for medical device manufacturers, covering the 2025 DOJ guidelines, historical cases, distributor red flags, and QMS controls.

›
Reimbursement & Market Access

DMEPOS Prior Authorization for Devices: Master, Required & the 2026 Exemption

A comprehensive guide to traditional Medicare DMEPOS prior authorization. Understand the Master and Required lists, the 2026 updates, and the 90% supplier exemption.

›
Reimbursement & Market Access

Medicare Advantage Prior Authorization for Medical Devices: Navigating the 2026 Rules

A comprehensive guide to Medicare Advantage prior authorization for medical devices. Learn about CMS-0057-F timelines, CY2026 rules, denial rates, and appeal strategies.

›
Reimbursement & Market Access

Outcomes-Based & Value-Based Contracts for Medical Devices: Commercial Playbook

A comprehensive guide to structuring outcomes-based and value-based contracts for medical devices. Analyzes OIG safe harbors, Stark Law, metrics, and case studies.

›
Commercialization

Hospital Value Analysis Committees and GPOs: How US Medical Devices Get Bought

Playbook on US hospital Value Analysis Committees (VAC) and Group Purchasing Organizations (GPOs). Explains evaluation rubrics and contracting pathways.

›
Regulatory

Panama Medical Device Registration: The DNDM Law 90 Compliance Guide

A comprehensive regulatory guide to medical device registration and licensing in Panama under DNDM, Law 90, Executive Decree 490, and Law 419.

›
Commercialization

Aesthetic Device Market Structure: FDA 510(k) and PMA Approvals Analysis

A data-driven map of the US aesthetic medical device market, analyzing 510(k) energy devices, the laser oligopoly, PMA implants (dermal fillers and breast implants), and recalls.

›
Regulatory

Burundi Essential Medical Devices List Teardown: ABREMA 2025

A data-driven teardown of Burundi's National Essential Medical Devices List (2025). Analyze the risk-class split, clinical-service mix, WHO-style tomes, and ABREMA legal framework.

›
Regulatory

Malawi PMRA Medical Device Register Teardown: Supplier Landscape

A data-driven teardown of Malawi's PMRA Medical Device Register. Analyze the supplier landscape, geographic concentration, registration timeline, and PMRA legal framework.

›
Regulatory

Mongolia Diagnostic & IVD Device Register Teardown: 2024 LMMD Reset

A data-driven teardown of Mongolia's diagnostic and IVD register. Analyze the risk-class split, country-of-origin mix, top manufacturers, and 2024 LMMD regulatory reset.

›